We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Accused of Double Standard In Advisory Board Waivers
FDA Accused of Double Standard In Advisory Board Waivers
September 22, 2006
The FDA’s recent decision to drop an advisory panel member shows that the agency uses a double standard in applying its conflict-of-interest policies, activists say.